Draegerwerk AG & Co KGaA
LSE:0K5E
Draegerwerk AG & Co KGaA
Draegerwerk AG & Co KGaA is a DE-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Luebeck, Schleswig-Holstein and currently employs 15,900 full-time employees. Draegerwerk AG & Co KGaA is a Germany-based provider of medical and safety technology. The firm operates through two segments: Medical and Safety. The Medical segment develops, produces and markets system solutions, equipment and services for the optimization of processes at the acute point of care, such as emergency care, preoperative care, critical care and prenatal care. The Safety segment develops, produces and markets products, system solutions and services for personal protection, gas detection technology and integrated hazard management for customers from various industries, such as mining, fire departments, police and disaster protection. The firm has production sites in Europe, the Americas, Africa and Asia.
Draegerwerk AG & Co KGaA is a DE-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Luebeck, Schleswig-Holstein and currently employs 15,900 full-time employees. Draegerwerk AG & Co KGaA is a Germany-based provider of medical and safety technology. The firm operates through two segments: Medical and Safety. The Medical segment develops, produces and markets system solutions, equipment and services for the optimization of processes at the acute point of care, such as emergency care, preoperative care, critical care and prenatal care. The Safety segment develops, produces and markets products, system solutions and services for personal protection, gas detection technology and integrated hazard management for customers from various industries, such as mining, fire departments, police and disaster protection. The firm has production sites in Europe, the Americas, Africa and Asia.
Strong Q3: Dräger delivered a strong third quarter with significant net sales and EBIT growth, more than doubling EBIT compared to the prior year quarter.
Guidance Upgraded: The company now expects both net sales growth and EBIT margin to be in the upper half of its previous guidance range for the full year.
Order Momentum: Order intake rose by 9% in the first 9 months, reaching EUR 2.6 billion, the highest level since the pandemic-driven record year of 2020.
Margin Expansion: Gross margin improved by 0.7 percentage points to 45.1%, and EBIT margin in Q3 jumped to 6.8%.
Cash Flow: Operating cash flow increased by more than EUR 35 million to around EUR 93 million for the first 9 months.
Market Share: Management believes Dräger has captured its fair share in the ventilator market after key competitors exited, and expects continued growth opportunities.
Geographic Trends: Strong growth in Americas and EMEA offset weaker performance in China and Germany.
Cautious on Q4 Margins: Management expects Q4 margins to normalize and possibly decline slightly from Q3's exceptionally strong level.
